Stuart Poulton, EVP, Chief Development Officer: Karyopharm Therapeutics KPTI Sell · Filed 25/02/19

Trade details

Type: Insider sale
Amount: $3,725.82
Shares · price: 5,914 sh · $0.63 a share
Held after: 320,714 sh
Stock: Karyopharm Therapeutics KPTI
Person: Stuart PoultonEVP, Chief Development Officer
Trade date: 25/02/18
Filed: 25/02/19
Days to filing: 1 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

Karyopharm Therapeutics trades, last 26 weeks

What else happened in Karyopharm Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/19~25/03/20

Stuart Poulton's recent trades

Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,829
403 sh
$3,829
Filed 05/15
Traded 05/14
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$48K
5,101 sh
$48K
Filed 03/03
Traded 03/02
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$3,262
378 sh
$3,262
Filed 02/19
Traded 02/17
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$2,578
401 sh
$2,578
Filed 25/09/16
Traded 25/09/15
Stuart PoultonEVP, Chief Development Officer
SellKaryopharm Therapeutics
Sell
Karyopharm Therapeutics
KPTI
$835
191 sh
$835
Filed 25/07/30
Traded 25/07/29